18 and older, any sex, with Weight Loss. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in WeightPrimary· baseline and 4 weeks
Comparison of weight change from baseline between arms
Group
Value
95% CI
Laser for 4 Weeks
-0.5
± 1.7
Laser for 6 Weeks
-0.9
± 1.7
Laser for 12 Weeks
-0.6
± 1.5
Change in Waist CircumferencePrimary· baseline and 4 weeks
Comparison of waist circumference change from baseline between arms
Group
Value
95% CI
Laser for 4 Weeks
-1.4
± 2.3
Laser for 6 Weeks
-2.0
± 2.5
Laser for 12 Weeks
-0.8
± 2.6
Adverse events — posted to ClinicalTrials.gov
Time frame: Adverse events were collected during LLLT treatment for each group (4 weeks for group A; 6 weeks for group B; 12 weeks for group C)..
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
The purpose of this research is to gather preliminary information on the effectiveness of Low Level Laser Therapy (LLLT) in helping people reduce their weight gain in the central body region.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
· Phase 2
· recruiting
NCT07223983 — Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
· Phase 1
· recruiting
NCT07213466 — Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
· Phase 4
· recruiting
NCT06785064 — Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
· NA
· recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2).
· NA
· recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
· NA
· not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
· not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance,
· NA
· not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
· NA
· recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 13 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02877004.